Market Cap 384.56B
Revenue (ttm) 61.16B
Net Income (ttm) 4.23B
EPS (ttm) N/A
PE Ratio 21.31
Forward PE 14.60
Profit Margin 6.91%
Debt to Equity Ratio -20.91
Volume 5,702,900
Avg Vol 7,280,538
Day's Range N/A - N/A
Shares Out 1.77B
Stochastic %K 71%
Beta 0.34
Analysts Strong Sell
Price Target $249.82

Company Profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 847 932 7900
Address:
1 North Waukegan Road, North Chicago, United States
Guntz
Guntz Apr. 2 at 2:38 AM
$ABBV Our time to shine again?
0 · Reply
leshgo
leshgo Apr. 1 at 10:39 PM
$VKTX 's VK2735 looks highly promising. It's well known that $ABBV is aggressively making moves to enter the obesity drug market. To have their planned obesity treatment factory up and running by 2029, who do you think they need? I think $VKTX I suspect Big Pharma is holding out for the results of $VKTX's upcoming Q3 maintenance data. The obesity market is absolutely massive, and for major pharmaceutical companies facing patent cliffs, this is a dream asset.
0 · Reply
NvidiaKing
NvidiaKing Apr. 1 at 8:21 PM
$ABBV piece of shit 💩 company. Worked for them. Horrible company and culture
0 · Reply
Guntz
Guntz Apr. 1 at 8:19 PM
$ABBV Shaking out weak hands. Institutionals steadily buying.
0 · Reply
flabb
flabb Apr. 1 at 4:49 PM
$ABBV 208.75 limit order in.
0 · Reply
flabb
flabb Apr. 1 at 4:45 PM
$ABBV 210 or lower i would be interested, she is 214.82 right now
0 · Reply
Oldpuck
Oldpuck Apr. 1 at 4:38 PM
$ABBV Almost all pharma up today except...
1 · Reply
TalkMarkets
TalkMarkets Apr. 1 at 4:10 PM
ABBV: An Attractive Income Stock In This Turbulent Market $ABBV $SPX https://talkmarkets.com/article/abbv-an-attractive-income-stock-in-this-turbulent-market-1775058178
0 · Reply
Guntz
Guntz Apr. 1 at 3:18 PM
$ABBV Dang hopefully just a shake out
0 · Reply
Guntz
Guntz Apr. 1 at 2:10 PM
$ABBV Expected selling as it hit the $220 wall.
0 · Reply
Latest News on ABBV
AbbVie to Host First-Quarter 2026 Earnings Conference Call

Mar 31, 2026, 8:00 AM EDT - 1 day ago

AbbVie to Host First-Quarter 2026 Earnings Conference Call


AbbVie: Strong 2026 Outlook, Expect Dividend Increases

Mar 27, 2026, 2:42 PM EDT - 5 days ago

AbbVie: Strong 2026 Outlook, Expect Dividend Increases


Buy Or Fear AbbVie Stock At $210?

Mar 19, 2026, 9:26 AM EDT - 13 days ago

Buy Or Fear AbbVie Stock At $210?


Best Dividend Kings: March 2026

Mar 19, 2026, 3:27 AM EDT - 14 days ago

Best Dividend Kings: March 2026

ABM ABT ADM ADP AWR BDX BKH


Harbor Health Care ETF Q4 2025 Portfolio Review

Mar 11, 2026, 8:18 AM EDT - 21 days ago

Harbor Health Care ETF Q4 2025 Portfolio Review

ABVX GMAB LLY MASI MEDI MRK RVMD


February Dividends With 4 Raises: 1.6% Up To 14.5%

Mar 3, 2026, 8:14 AM EST - 4 weeks ago

February Dividends With 4 Raises: 1.6% Up To 14.5%

BMY BTI MA


Best Dividend Aristocrats For March 2026

Feb 27, 2026, 12:21 PM EST - 4 weeks ago

Best Dividend Aristocrats For March 2026

ABT ADM ADP AFL ALB AMCR AOS


AbbVie Declares Quarterly Dividend

Feb 19, 2026, 9:37 AM EST - 5 weeks ago

AbbVie Declares Quarterly Dividend


AbbVie: Dominating Immunology While Building Oncology Upside

Feb 17, 2026, 1:11 AM EST - 6 weeks ago

AbbVie: Dominating Immunology While Building Oncology Upside


AbbVie sues US health agency over Botox price controls

Feb 11, 2026, 6:49 PM EST - 7 weeks ago

AbbVie sues US health agency over Botox price controls


Abbvie sues US health agency over Botox

Feb 11, 2026, 5:13 PM EST - 7 weeks ago

Abbvie sues US health agency over Botox


2 Urgent Sells And 2 No Brainer Dividend Buys

Feb 11, 2026, 4:06 PM EST - 7 weeks ago

2 Urgent Sells And 2 No Brainer Dividend Buys

AEP AMGN BMY ESS HASI HD PFE


Dividend Kings: No Ideal Buys In February's 57

Feb 10, 2026, 9:45 AM EST - 7 weeks ago

Dividend Kings: No Ideal Buys In February's 57

ABM ADP CWT FRT FTS HRL HTO


AbbVie: The Market Is Getting It Wrong

Feb 5, 2026, 8:52 AM EST - 7 weeks ago

AbbVie: The Market Is Getting It Wrong


AbbVie Q4 Earnings Review: I May Have Just Made A Huge Mistake

Feb 4, 2026, 5:45 PM EST - 2 months ago

AbbVie Q4 Earnings Review: I May Have Just Made A Huge Mistake


AbbVie Inc. (ABBV) Q4 2025 Earnings Call Transcript

Feb 4, 2026, 1:20 PM EST - 2 months ago

AbbVie Inc. (ABBV) Q4 2025 Earnings Call Transcript


AbbVie Revenue Rises on Immunology Growth

Feb 4, 2026, 8:34 AM EST - 2 months ago

AbbVie Revenue Rises on Immunology Growth


Guntz
Guntz Apr. 2 at 2:38 AM
$ABBV Our time to shine again?
0 · Reply
leshgo
leshgo Apr. 1 at 10:39 PM
$VKTX 's VK2735 looks highly promising. It's well known that $ABBV is aggressively making moves to enter the obesity drug market. To have their planned obesity treatment factory up and running by 2029, who do you think they need? I think $VKTX I suspect Big Pharma is holding out for the results of $VKTX's upcoming Q3 maintenance data. The obesity market is absolutely massive, and for major pharmaceutical companies facing patent cliffs, this is a dream asset.
0 · Reply
NvidiaKing
NvidiaKing Apr. 1 at 8:21 PM
$ABBV piece of shit 💩 company. Worked for them. Horrible company and culture
0 · Reply
Guntz
Guntz Apr. 1 at 8:19 PM
$ABBV Shaking out weak hands. Institutionals steadily buying.
0 · Reply
flabb
flabb Apr. 1 at 4:49 PM
$ABBV 208.75 limit order in.
0 · Reply
flabb
flabb Apr. 1 at 4:45 PM
$ABBV 210 or lower i would be interested, she is 214.82 right now
0 · Reply
Oldpuck
Oldpuck Apr. 1 at 4:38 PM
$ABBV Almost all pharma up today except...
1 · Reply
TalkMarkets
TalkMarkets Apr. 1 at 4:10 PM
ABBV: An Attractive Income Stock In This Turbulent Market $ABBV $SPX https://talkmarkets.com/article/abbv-an-attractive-income-stock-in-this-turbulent-market-1775058178
0 · Reply
Guntz
Guntz Apr. 1 at 3:18 PM
$ABBV Dang hopefully just a shake out
0 · Reply
Guntz
Guntz Apr. 1 at 2:10 PM
$ABBV Expected selling as it hit the $220 wall.
0 · Reply
Guntz
Guntz Apr. 1 at 1:37 PM
$ABBV Bust through that $220 wall!
0 · Reply
green_going_up
green_going_up Apr. 1 at 3:50 AM
$CLGN Aesthetic Wellness is one of the fastest growing markets; this firm has a development deal with $ABBV yet can't get any interest; reminds me of $LCTX which has a development deal with $RHHBY for GA; these firms get tiny milestone payments and just sit there waiting, hoping, and praying for these big firms to fully commit. They can take YEARS. And, you wonder if firm's like Abbvie and Roche don't just play the long game on purpose, eventually being able to pick up these micro-cap firm assets on the cheap once either these firms file for bankruptcy or dilute themselves so much because the shorts / naked shorts just pound them relentless until they are forced to de-list. Firms like these micro-cap ones MUST have really strong CFO's to raise way more than what's needed - Years Worth of Cash - in the period right after the initial partnership announcement spike. Otherwise, surviving the waiting game is a serious challenge.
2 · Reply
SuperGreenToday
SuperGreenToday Mar. 31 at 11:17 PM
$ABBV Share Price: $217.43 Contract Selected: Apr 24, 2026 $215 Calls Buy Zone: $5.78 – $7.14 Target Zone: $10.60 – $12.96 Potential Upside: 73% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Guntz
Guntz Mar. 31 at 7:47 PM
$ABBV Bust $220 soon and $230 comes quick
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Mar. 31 at 7:22 PM
$SLS @ezimon most don't realize how big the VERONA Failure is... - no Improvement in Overall Survival for High RISK MDS which is basically AML. - partly why $ABBV shut. down the VIALE-M trial for AML FIRST REMISSION Maintenance - there was no OS Benefit. - and there is No OS Benefit for the. SLS REGAL Control Patients - Just like Dr. Tsirigotis, Dr. Jamy and Dr. Levy have all Also, Stated on the Record. -- only the Truly DumbasF idiots can't understand - its GPS - Gps is the Only Reason we are seeing MIRACULOUS ALL Pooled Survival in the REGAL P3 Patients.
0 · Reply
Guntz
Guntz Mar. 31 at 5:20 PM
$ABBV Noooo markets don't leave us behind 😭
0 · Reply
OptionSamurai
OptionSamurai Mar. 31 at 2:53 PM
$ABBV appears in our scan that looks for calls that will explode if the stock goes to analyst target. Analysts rating is BUY and the target price is 17.8% away📈. Call 230.0, 18-Jun-26 has: Max loss of 3.5% compared to holding shares and Breakeven is 9.6% away. If the stock hits the target, the call will profit 235% 🔥🔥🔥. 👉 Create your own scan here: https://bit.ly/3lR1xIP
0 · Reply
Guntz
Guntz Mar. 31 at 2:37 PM
$ABBV $219 a big supply zone. Tough nut to crack
0 · Reply
Guntz
Guntz Mar. 31 at 2:20 PM
$ABBV Maybe too much too fast.
0 · Reply
GrapeGatsby
GrapeGatsby Mar. 31 at 2:03 PM
$ABBV Might find resistance at 220 end of gap fill and previous support.
0 · Reply
Guntz
Guntz Mar. 31 at 2:02 PM
$ABBV Let's fucking go!
0 · Reply
GrapeGatsby
GrapeGatsby Mar. 31 at 2:02 PM
$ABBV Damn nice momentum congrats bulls.
0 · Reply